News

A specialized RNA with a memorable acronym, SLAMR, plays a role in fear conditioning, according to a discovery from scientists led by Sathya Puthanveettil, Ph.D..

Molecular biologist Ezgi Hacisuleyman, Ph.D., investigates how neurons respond to signals, changing in milliseconds. She recently joined the institute from The Rockefeller University.

The new gift will help expand the institute’s high school internships, its graduate fellowships, and its kindergarten through collegiate educational outreach programs, which include school visits, field trips, science night participation and other events.

At “Innovating for Cures,” an event held at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology on Wednesday, innovators, philanthropists and venture capital investors discussed what’s required to accelerate biomedical research advances out of the lab and into the clinic.

The research shows how excess cholesterol in cell membranes may interfere with pain control.

Hattori focuses on understanding and mapping how the brain integrates information to make decisions.

A new discovery from the lab of chemist Matthew Disney, Ph.D., takes its inspiration from Greek mythology. The compound is a chimera, and it battles a toxic cause of Parkinson's in two ways.

Scientists have discovered two useful new enzymes which may help them create medicines for cancer and other conditions. The enzymes were found in the Natural Products Discovery Center collection.

Predicting who could benefit from a given drug has been difficult. An international team led by neuroscientist Kirill Martemyanov, Ph.D., is training AI to assist.

Chemistry Professor Thomas Kodadek, Ph.D., has won a third Transformative Research Award from the National Institutes of Health for his plan to capitalize on cells' protein recycling machinery as a way to fight cancer.